PSMD1 and chronic myelogenous leukemia, BCR-ABL1 positive: We recently demonstrated that knockdown of PSMD1 and PSMD3 resulted in increased apoptosis of CML cells but not normal cord blood controls, implicating they may be good targets for therapy [31].